Picture of PharmAbcine logo

208340 — PharmAbcine News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: PharmAbcine Execute An Agreement With Thermo Fisher For Development, Manufacturing Of Its Next-Generation Immune Checkpoint Blockade

June 10 (Reuters) - PharmAbcine Inc  208340.KQ :
    * PHARMABCINE EXECUTE AN AGREEMENT WITH THERMO FISHER FOR
THE
DEVELOPMENT AND MANUFACTURING OF ITS NEXT-GENERATION IMMUNE
CHECKPOINT BLOCKADE, PMC-309 FOR PHASE I

Source text for Eikon:  ID:nPn7TlHyma 
Further company coverage:  208340.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on PharmAbcine

See all news